Prelude Therapeutics Incorporated (NASDAQ:PRLD) Q3 2025 Earnings Call Transcript

Prelude Therapeutics Incorporated (NASDAQ:PRLD) Q3 2025 Earnings Call Transcript November 12, 2025

Prelude Therapeutics Incorporated beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.35.

Operator: Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today’s call is being recorded and is expected to last up to 45 minutes. At this time, I will now turn the call over to Prelude’s Chief Financial Officer and Chief Legal...